Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Artemis, Ascent, Blencowe,
RNS Hotlist with Zak Mir: POLB, QTZ, ALL, DEV, EEE, ZPHR, ONC, PXEN, 1SN, SML, EQT, CCZ, CBX & COBR
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, announced that further to the Option.
Poolbeg Pharma PLC (AIM:POLB) completes in-licence of Melioidosis vaccine candidate
Targeting an infectious disease with a high mortality rate and growing incidence driven by climate change
RNS Hotlist with Zak Mir: I3E, TGR, COPL, GGP, GSCU, SAR, RGO, POLB, ODX, UKOG, PHE, CNR & THX
i3 Energy (I3E), an independent oil and gas company, announced unaudited results for its period ended 30 June 2022.
Poolbeg Pharma PLC (AIM:POLB) to attend HC Wainwright Global Investment Conference, New York City, USA
12 September 2022 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model.
Share Talk Weekly Stock Market News, Sunday 11th September 2022
Share Talk is very happy to announce we will be hosting an Investor Presentation followed by a Q&A with Paul Johnson, CEO of Power Metal Resources on 15th September 2022.
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 6th September 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Contango, Canadian, Cleantech,
RNS Hotlist with Zak Mir: POLB, FDBK, CGH, PANR, BRES, SYN, OMI, CGO, ORCP, OBI, CBX & ECHO
Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, announced its unaudited interim results for the six months to 30 June 2022.
Poolbeg Pharma PLC (AIM:POLB) Interim results for the six months to 30 June 2022
Significant strategic and operational progress
Poolbeg Pharma – Climate crisis is creating the perfect storm for infectious diseases
As global temperatures have gone up, so too have outbreaks of many infectious illnesses. Climate change has exacerbated 218 out of 375 conditions
Poolbeg Pharma PLC (AIM:POLB) Notice of Results
31 August 2022 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, will announce
